BCI Marketplace
Deep Brain Stimulation trials

Glucose Consumption During Deep Brain Stimulation With Functional [18F]FDG-Brain-PET in Obsessive-Compulsive Disorder

RecruitingNCT05577598Phase: NAStarted 2022-04-01

Summary

The purpose of this randomized, sham-controlled study is to evaluate the effectiveness of DBS therapy in individuals suffering from severe OCD and to investigate DBS treatment with functional \[18F\]FDG-Brain-PET.

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
75 Years

Inclusion Criteria: * a score of 25 or higher on the Yale-Brown Obsessive Compulsive Scale * previous failure to respond to at least two medication trials with serotonin reuptake inhibitors at or, if tolerated, beyond the FDA maximum recommended dose for a minimum duration over at least ten weeks e

Locations

Medical University of Vienna, Department of Psychiatry and Psychotherapy
Vienna, State of Vienna, Austria

Interested in participating? View the full study details on ClinicalTrials.gov:

View on ClinicalTrials.gov →